About IntelliSyn
IntelliSyn is a Healthcare company based in Montreal (Canada) founded in 2011, and was acquired by X-Chem in January 2021. CRO offers synthetic, computational, analytical and in vitro and in vivo drug discovery services. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry.
Company details
IntelliSyn was founded in 2011 in Montreal, Canada, as a contract research organization in the pharmaceutical sector. Services encompass synthetic chemistry, computational modeling, analytical techniques, in vitro assays, and in vivo studies to support drug development. Operations are centered on collaborative research for biotech and pharmaceutical clients, with a focus on efficient discovery processes.
- Headquarters Montreal, Canada
- Stage Acquired
- SectorsHealthcare
- Website intellisynrd.com
- Acquired by X-Chem (Jan 2021)
Investors in IntelliSyn
IntelliSyn has secured backing from 1 investor. Prominent investors backing the company include X-Chem.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Small molecule drug discovery platform is provided to researchers. | 2009 | x-chemrx.com | Waltham, United States |
Investor details for IntelliSyn
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of IntelliSyn
2 dated milestones of IntelliSyn across 10 years, from founding to its latest funding, stage changes and deals.
- Founded IntelliSyn is founded.
- Exit Acquired by X-Chem.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IntelliSyn
IntelliSyn was founded in 2011.
IntelliSyn is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
IntelliSyn was founded in 2011 in Montreal, Canada, as a contract research organization in the pharmaceutical sector. Services encompass synthetic chemistry, computational modeling, analytical techniques, in vitro assays, and in vivo studies to support drug development. Operations are centered on collaborative research for biotech and pharmaceutical clients, with a focus on efficient discovery processes.
IntelliSyn has 1 investor. Key investors include X-Chem.
Yes. IntelliSyn was acquired by X-Chem in January 2021.